AstraZeneca links with Alibaba and Tencent in China push
#1
AstraZeneca links with Alibaba and Tencent in China push



LONDON - AstraZeneca has clinched two new deals with Chinese tech giants Alibaba and Tencent as the British drugmaker steps up its drive to expand business in China. 
China is now the world’s second-largest drugs market behind the United States and is a particular bright spot for AstraZeneca, accounting for 15 percent of its drug sales -- a far higher proportion than at other big pharmaceutical companies.

AstraZeneca’s sales in China grew 30 percent in the last quarter of 2017 and Chief Executive Pascal Soriot expects them to continue to increase at a “low-20s” percentage rate.   

The deal with Tencent, meanwhile, involves the development of online tracking systems to fight counterfeit medicines -- a common problem in China.
Both deals were announced on Friday Feb/2 , alongside AstraZeneca’s full-year results. 

AstraZeneca is in a strong position in China after recently having had five new products added to the National Reimbursement Drug List - Onglyza for diabetes, cancer drugs Iressa and Faslodex, heart medicine Brilinta and antipsychotic treatment Seroquel. 



https://www.reuters.com/article/us-astra...SKBN1FM1FM








________________________________

[Image: Chuc_MNM.gif]
Reply